"At first it was such a shock, to think of taking in a blood product — and now it just amazes me how it's become a normal part of my life."

Stacy
Alpha-1 Patient

See how Prolastin^® has made a difference in the lives of 3 people with AAT deficiency.

Read More

Prolastin^® is used for alpha₁-antitrypsin
(AAT) deficiency in adults with emphysema.
Since 1988, physicians and patients have relied on
Prolastin^® as a critical part of the total treatment regimen.

Important Safety Information

Prolastin^®, Alpha₁-Proteinase Inhibitor (Human) is indicated for chronic replacement therapy of individuals having congenital deficiency of alpha-1 PI (alpha₁-antitrypsin deficiency) with clinically demonstrable panacinar emphysema. Weekly Prolastin^® therapy has demonstrated a low occurrence of side effects. In clinical studies with Prolastin^®, reactions were observed in 1.16% of infusions, the most common events being fever (0.77%), light-headedness (0.19%), and dizziness (0.19%). As with all plasma-derived therapeutics, the potential to transmit infectious agents cannot be totally eliminated. Individuals with selective IgA deficiencies who have known antibody against IgA (anti-IgA antibody) should not receive Prolastin^®, since these patients may experience severe reactions, including anaphylaxis, to IgA which may be present.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please click here for Prolastin^® full Prescribing Information.

Remember, your doctor or healthcare provider is the single best source of information regarding you and your health. Please consult your doctor or healthcare provider if you have any questions about your health or any of your medications.

Sign up to receive newsletters and updates.

Register Now!